Twine Health

Robert S. Huckman; Ariel D.  Stern

Teaching Note | HBS Case Collection | March 2018

Twine Health

Abstract

In late 2014, Dr. John Moore (CEO), Frank Moss (chairman), and Scott Gilroy (CTO) of Twine Health (Twine) had to resolve several challenges that threatened to restrict the widespread dissemination of its sole product, Twine. Twine was a cloud-based platform that enabled patients to create and manage chronic disease treatment plans in conjunction with their primary care providers and specialized coaches. Twine had already enjoyed impressive successes in early clinical trials and among early adopters. The issues Twine's leadership team had to address included identifying clinical care providers willing to pay for Twine, ensuring adoption and effective use by both patients and health care providers, adding capabilities to support the management of additional chronic diseases, and seamlessly integrating Twine with a client organization's electronic medical record (EMR) system and information technology (IT) infrastructure. The need to solve these problems had become more pressing since Twine was named a finalist in the Health Acceleration Challenge (HAC) sponsored by Harvard Business School and Harvard Medical School. Teaching Note for HBS No. 615-068.

Keywords: health care; chronic disease; technology adoption; digital health; health acceleration challenge; information technology; health; strategy; disease management; Health; Health Care and Treatment; Information Technology; Mobile Technology; Technology Adoption; Health Industry; United States; Massachusetts;

Language: English

Format: Print

19 pages

Purchase

Citation:

Huckman, Robert S., and Ariel D. Stern. "Twine Health." Harvard Business School Teaching Note 618-055, March 2018.

National retailers, most notably Walmart and Best Buy, are making big bets on their ability to fill this need for local health care. At first glance, these moves are a bit surprising given that these companies have not traditionally been focused on health care delivery. But inroads made by e-retailers has left these companies with two sets of resources—large store locations and an army of low-wage employees—that are at risk of becoming stranded assets. And recent announcements from Walmart and Best Buy suggest that the companies may see the provision of local health care as an opportunity to redeploy their store employees.

The development of intelligent machines holds great promise for making health care delivery more accurate, efficient, and accessible, but challenges remain for incorporating AI into clinical and administrative settings.

This case provides an update to the (A) case, which introduces students to adaptive platform trials, an ambitious, more efficient type of clinical trial that increases access to therapies. The A case centers on Dr. Brian Alexander’s efforts to launch an adaptive platform trial for studying potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. The (B) case provides an update and explores the strategies that Alexander is considering for sustainably financing this trial.

Faculty & Research

Twine Health

Abstract

Citation:

About the Authors

More from these Authors